In addition, because EGFR plays a vital role in the regulation of cell proliferation, survival and differentiation [31], partial normalization of tumor vessels by bevacizumab could cause proliferation of the tumor cells, which could make them more sensitive to EGFR TKI. This evidence concerns the gene EGFR and neoplasm.